Simple gel may prevent painful side effect of liver cancer drug

NCT ID NCT07560566

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests if applying a topical gel (indomethacin) to the hands before starting sorafenib can prevent or reduce hand-foot skin reactions, a common and painful side effect. About 39 adults with advanced liver cancer will use the gel twice daily for up to 12 weeks. The goal is to see if this simple approach helps patients stay on their cancer treatment with less discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAND FOOT SKIN SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Taiwan University Hospital

    RECRUITING

    Taipei, 10002, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.